EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

Safety and efficacy of glucagon‐like peptide‐1 (GLP‐1) receptor agonists in patients with weight regain or insufficient weight loss after metabolic bariatric surgery: A systematic review and meta‐analysis

Ali Esparham, Ali Mehri, Amin Dalili, Jesse Richards, Zhamak Khorgami iD

Obesity Reviews · 2024-11 · 25 (11)

DOI: 10.1111/obr.13811 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Obesity Reviews, online erschienen am 12.08.2024. Verfasst von Ali Esparham und 4 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Bariatric Surgery, Liraglutide, Weight Gain, Weight Loss. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 59 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Weight regain and insufficient weight loss are major challenges after metabolic bariatric surgery (MBS), affecting patients' comorbidities and quality of life. The current systematic review and meta‐analysis aim to assess the efficacy and safety of GLP‐1 receptor agonists (GLP‐1 RA) in patients with weight regain or insufficient weight loss after MBS.

Methods

A systematic search was conducted across PubMed, Embase, Scopus, and Web of Science databases to find the relevant studies.

Results

A total of 19 articles were included. The highest doses of liraglutide and semaglutide were 3 mg per day and 1 mg once weekly, respectively, in the included studies. The mean differences in weight and body mass index after treatment were −7.02 kg or 3.07 kg/m 2 , −8.65 or −5.22 kg/m 2 , and −6.99 kg or −3.09 kg/m 2 for treatment durations of ≤ 6 months, 6–12 months, and >12 months with liraglutide, respectively. Additionally, weekly semaglutide showed significantly greater weight loss compared to daily liraglutide, with a mean difference of 4.15 kg. Common complications included nausea (19.1%), constipation (8.6%), abdominal pain (3.7%), and vomiting (2.4%).

Conclusion

Using GLP‐1 RA is a safe and effective treatment for weight regain and insufficient weight loss after MBS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bariatric SurgeryLiraglutideWeight GainWeight LossGlucagon-Like Peptide-1 Receptor AgonistsHumansObesityObesity, MorbidTreatment OutcomeSemaglutide

Stichwörter der Autor:innen

LiraglutideSemaglutidebariatric surgeryglucagon‐like peptide 1insufficient weight lossmorbid obesityobesityweight regain

Substanzen

LiraglutideGlucagon-Like Peptide-1 Receptor AgonistsSemaglutide

Autor:innen und Institutionen

  • Student Research Committee, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Endoscopic and Minimally Invasive Surgery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Department of General Surgery, School of Medicine, Surgical Oncology Research Center, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Department of Internal Medicine, University of Oklahoma School of Community Medicine, Tulsa, Oklahoma, USA.
  • Department of Surgery, University of Oklahoma, School of Community Medicine, Tulsa, Oklahoma, USA.
  • Harold Hamm Diabetes Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

ORCID-Profile: Zhamak Khorgami

Zitieren

APA

Esparham, A., Mehri, A., Dalili, A., Richards, J., & Khorgami, Z. (2024). Safety and efficacy of glucagon‐like peptide‐1 (GLP‐1) receptor agonists in patients with weight regain or insufficient weight loss after metabolic bariatric surgery: A systematic review and meta‐analysis. Obesity Reviews, 25(11). https://doi.org/10.1111/obr.13811

Vancouver

Esparham A, Mehri A, Dalili A, Richards J, Khorgami Z. Safety and efficacy of glucagon‐like peptide‐1 (GLP‐1) receptor agonists in patients with weight regain or insufficient weight loss after metabolic bariatric surgery: A systematic review and meta‐analysis. Obesity Reviews. 2024;25(11). doi:10.1111/obr.13811

BibTeX
@article{Esparham2024,
  author = {Esparham, Ali and Mehri, Ali and Dalili, Amin and Richards, Jesse and Khorgami, Zhamak},
  title = {Safety and efficacy of glucagon‐like peptide‐1 (GLP‐1) receptor agonists in patients with weight regain or insufficient weight loss after metabolic bariatric surgery: A systematic review and meta‐analysis},
  journal = {Obesity Reviews},
  year = {2024},
  volume = {25},
  number = {11},
  doi = {10.1111/obr.13811}
}
Kostenlos starten →